Four articles. Four minutes. | Issue #1
Surgery: Trabeculectomy slows visual field progression more than drops in advanced glaucoma
Diagnostics: Eyes with PXF developed glaucoma despite normal clinic IOP
Artificial Intelligence: Retinal biomarkers forecast 12-year glaucoma risk
Nutrition: Higher Niacin and B12 intake linked to lower OAG risk
Longitudinal visual field and quality of life change in the Treatment for Advanced Glaucoma Study
Methods
453 adults with newly diagnosed advanced OAG at 27 UK centers were randomized to trabeculectomy-first or medication-first care. The analysis modeled 5-year monocular VF, binocular integrated VF, and VFQ-25 change.
Results
Medication-first eyes lost monocular VF about twice as fast as trabeculectomy-first eyes (-0.75 vs -0.37 dB/year, p=0.002). Binocular VF and VFQ-25 change did not significantly differ.
Conclusion
Primary trabeculectomy slows visual field progression more than drops in advanced glaucoma, but this advantage is not detected by standard patient-reported quality-of-life measures.
Our Angle
This study adds to growing evidence that earlier intervention can better preserve visual field in glaucoma, even when patient-reported quality-of-life measures do not show a difference. In practice, this supports earlier consideration of surgical intervention in appropriate patients rather than relying on escalation of medical therapy alone, while recognizing that commonly used Quality of Life instruments may underestimate meaningful functional benefits.
Diagnostics
Development of Perimetric Glaucoma and Outcomes of Interventions in Pseudoexfoliation Syndrome With and Without Ocular Hypertension
Design: Retrospective cohort study
Journal: Ophthalmology
Authors: Fujita et al.
Among 369 patients (485 eyes) with pseudoexfoliation, 26.5% of eyes without ocular hypertension and 37.5% with ocular hypertension developed perimetric glaucoma within 4 years, with most cases occurring without documented IOP elevation at clinic visits. Older age, higher cup-to-disc ratio, ocular hypertension, and phakia were associated with higher risk, and standalone lens extraction reduced IOP by ~3 mmHg at 1 year.
Artificial Intelligence
Retinomics as a Tool for Glaucoma Prediction.
Design: Prospective UK Biobank cohort
Journal: Ophthalmology Science
Authors: Yusufu et al.
In a 40,949-participant UK Biobank cohort followed for ~12 years, combined retinal vascular and neural imaging (“retinomics”) strongly predicted incident glaucoma, with ~9-fold higher risk in the highest vs lowest risk group using only age, sex, and imaging features. These findings highlight retinomics as a simple, noninvasive tool for early glaucoma risk stratification, though validation in more diverse populations is needed.
Nutrition
Vitamin B intake is associated with lower incidence of open-angle glaucoma: the Rotterdam Study.
Design: Prospective population-based cohort
Journal: American Journal of Ophthalmology
Authors: van Haarlem et al.
Higher intake of vitamin B3 (niacin) and B12 was linked to a lower risk of developing open-angle glaucoma, along with trends toward lower IOP and better ganglion cell layer thickness; however, the observational design and reliance on a single baseline diet assessment limit conclusions about causality. Optimizing dietary intake or considering supplementation, especially in higher-risk patients, may be a simple adjunctive strategy for glaucoma prevention, but prospective trials are needed before routine recommendation.
Mount Sinai ophthalmologist reports first-in-human use of miDOC, a device designed to measure aqueous outflow during glaucoma surgery.
FDA pilots real-time clinical trial reporting, letting the agency view selected safety and endpoint data while studies are still underway.
IRIS Registry users may soon see AI-assisted Medicare quality reporting, aimed at reducing the MIPS documentation burden for ophthalmology practices.
OpenAI launches ChatGPT for Clinicians, offering free access to verified U.S. clinicians for documentation, medical research, and cited clinical search.
Which ophthalmologist remains the only ophthalmologist to win the Nobel Prize in Physiology or Medicine?
A. Hermann von Helmholtz
B. Hans Goldmann
C. Allvar Gullstrand
D. Charles Kelman
See answer at bottom of newsletter
Get the next issue in your inbox
The Open Angle is a weekly glaucoma research newsletter for busy ophthalmologists.
Four papers worth knowing, in under four minutes.
Edited by Jella An, MD, MBA and Jason Dossantos, MD.
The Open Angle is an educational editorial product. It is not medical advice. Readers should review original sources before changing practice.
Trivia Answer: C